Two-year results of a multicenter randomized controlled trial comparing Mechanochemical endovenous Ablation to RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA trial)



      Endothermal techniques have proved to be effective for treatment of incompetent truncal veins. The tumescentless mechanochemical ablation (MOCA) technique has become an alternative treatment modality, but its outcome with regard to endothermal techniques is still unclear.


      A multicenter prospective randomized controlled trial was designed comparing MOCA with radiofrequency ablation (RFA) to treat great saphenous vein incompetence with the hypothesis that MOCA is associated with less postprocedural pain and a comparable anatomic and clinical success rate at 1-year follow-up. Disease-specific quality of life and general health-related quality of life (HRQoL) were measured using questionnaires. Inclusion was terminated prematurely because reimbursement was suspended.


      A total of 213 patients (46.3% of intended number of patients) were randomized, of whom 209 were treated (105 in the MOCA group and 104 in the RFA group). Overall median pain scores during the first 14 days were lower after MOCA (0.2 vs 0.5 after RFA; P = .010), although the absolute difference was small. At 30 days, similar complication numbers (MOCA, n = 62; RFA, n = 63) and HRQoL scores (Aberdeen Varicose Vein Questionnaire: MOCA, 8.9; RFA, 7.6; P = .233) were observed. Hyperpigmentation was reported in seven patients in the MOCA group and two patients in the RFA group (P = .038). In the MOCA group, there were four complete failures (3.8%) compared with none in the RFA group (P = .045), although in one patient at 1 year, the vein showed occlusion. Median 30-day Venous Clinical Severity Score (VCSS) was significantly lower at 30 days after MOCA (1.0 vs 2.0 in the RFA group; P = .001), whereas VCSS was comparable at baseline (MOCA, 4.0; RFA, 5.0; P = .155). The 1- and 2-year anatomic success rate was lower after MOCA (83.5% and 80.0%) compared with RFA (94.2% and 88.3%; P = .025 and .066), mainly driven by partial recanalizations. After 2 years of follow-up, no differences were observed in the number of complete failures.
      Similar clinical success rates at 1 year (MOCA, 88.7%; RFA, 93.2%; P = .315) and 2 years (MOCA, 93.0%; RFA, 90.4%; P = .699) and no differences in HRQoL scores on the Aberdeen Varicose Vein Questionnaire at 1 year (MOCA, 7.5; RFA, 7.0; P = .753) and 2 years (MOCA, 5.0%; RFA, 4.8%; P = .573) were observed. There were two cardiac serious adverse events, a ventricular fibrillation in the MOCA group (1 year) and an unstable angina in the RFA group (2 years). One deep venous thrombosis occurred in the RFA group on 1-year duplex ultrasound, without clinical sequelae.


      Unilateral treatment with MOCA in the short term resulted in less postoperative pain but more hyperpigmentation compared with RFA and a faster improvement in VCSS. More anatomic failures were reported after MOCA, mostly driven by partial recanalizations, but both techniques were associated with similar clinical outcomes at 1 year and 2 years.


      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mallick R.
        • Lal B.K.
        • Daugherty C.
        Relationship between patient-reported symptoms, limitations in daily activities, and psychological impact in varicose veins.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 224-237
        • Wittens C.
        • Davies A.H.
        • Baekgaard N.
        • Broholm R.
        • Cavezzi A.
        • Chastanet S.
        • et al.
        Editor's choice—management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS).
        Eur J Vasc Endovasc Surg. 2015; 49: 678-737
        • Khilnani N.M.
        • Grassi C.J.
        • Kundu S.
        • D'Agostino H.R.
        • Khan A.A.
        • McGraw J.K.
        • et al.
        Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association.
        J Vasc Interv Radiol. 2010; 21: 14-31
        • van den Bos R.
        • Arends L.
        • Kockaert M.
        • Neumann M.
        • Nijsten T.
        Endovenous therapies of lower extremity varicosities: a meta-analysis.
        J Vasc Surg. 2009; 49: 230-239
        • Brittenden J.
        • Cotton S.C.
        • Elders A.
        • Ramsay C.R.
        • Norrie J.
        • Burr J.
        • et al.
        A randomized trial comparing treatments for varicose veins.
        N Engl J Med. 2014; 371: 1218-1227
        • Shepherd A.C.
        • Gohel M.S.
        • Brown L.C.
        • Metcalfe M.J.
        • Hamish M.
        • Davies A.H.
        Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins.
        Br J Surg. 2010; 97: 810-818
        • Shepherd A.C.
        • Gohel M.S.
        • Lim C.S.
        • Hamish M.
        • Davies A.H.
        Pain following 980-nm endovenous laser ablation and segmental radiofrequency ablation for varicose veins: a prospective observational study.
        Vasc Endovascular Surg. 2010; 44: 212-216
        • Proebstle T.M.
        • Alm B.J.
        • Gockeritz O.
        • Wenzel C.
        • Noppeney T.
        • Lebard C.
        • et al.
        Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins.
        Br J Surg. 2015; 102: 212-218
        • Proebstle T.M.
        • Alm J.
        • Gockeritz O.
        • Wenzel C.
        • Noppeney T.
        • Lebard C.
        • et al.
        Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities.
        J Vasc Surg. 2011; 54: 146-152
        • Whiteley M.S.
        • Shiangoli I.
        • Dos Santos S.J.
        • Dabbs E.B.
        • Fernandez-Hart T.J.
        • Holdstock J.M.
        Fifteen year results of radiofrequency ablation, using VNUS Closure, for the abolition of truncal venous reflux in patients with varicose veins.
        Eur J Vasc Endovasc Surg. 2017; 54: 357-362
        • Lawson J.A.
        • Gauw S.A.
        • van Vlijmen C.J.
        • Pronk P.
        • Gaastra M.T.
        • Tangelder M.J.
        • et al.
        Prospective comparative cohort study evaluating incompetent great saphenous vein closure using radiofrequency-powered segmental ablation or 1470-nm endovenous laser ablation with radial-tip fibers (Varico 2 study).
        J Vasc Surg Venous Lymphat Disord. 2018; 6: 31-40
        • Hamann S.A.
        • Giang J.
        • De Maeseneer M.G.
        • Nijsten T.E.
        • van den Bos R.R.
        Editor's choice—five year results of great saphenous vein treatment: a meta-analysis.
        Eur J Vasc Endovasc Surg. 2017; 54: 760-770
        • Kugler N.W.
        • Brown K.R.
        An update on the currently available nonthermal ablative options in the management of superficial venous disease.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 422-429
        • Sun J.J.
        • Chowdhury M.M.
        • Sadat U.
        • Hayes P.D.
        • Tang T.Y.
        Mechanochemical ablation for treatment of truncal venous insufficiency: a review of the current literature.
        J Vasc Interv Radiol. 2017; 28: 1422-1431
        • Witte M.E.
        • Zeebregts C.J.
        • de Borst G.J.
        • Reijnen M.
        • Boersma D.
        Mechanochemical endovenous ablation of saphenous veins using the ClariVein: a systematic review.
        Phlebology. 2017; 32: 649-657
        • van Eekeren R.R.
        • Boersma D.
        • Holewijn S.
        • Vahl A.
        • de Vries J.P.
        • Zeebregts C.J.
        • et al.
        Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial.
        Trials. 2014; 15: 121
        • Kistner R.L.
        • Eklof B.
        • Masuda E.M.
        Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification.
        Mayo Clin Proc. 1996; 71: 338-345
        • Rutherford R.B.
        • Padberg Jr., F.T.
        • Comerota A.J.
        • Kistner R.L.
        • Meissner M.H.
        • Moneta G.L.
        Venous severity scoring: an adjunct to venous outcome assessment.
        J Vasc Surg. 2000; 31: 1307-1312
        • Rasmussen L.H.
        • Lawaetz M.
        • Bjoern L.
        • Vennits B.
        • Blemings A.
        • Eklof B.
        Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.
        Br J Surg. 2011; 98: 1079-1087
        • van Eekeren R.R.
        • Boersma D.
        • Elias S.
        • Holewijn S.
        • Werson D.A.
        • de Vries J.P.
        • et al.
        Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study.
        J Endovasc Ther. 2011; 18: 328-334
        • van Eekeren R.R.
        • Boersma D.
        • Konijn V.
        • de Vries J.P.
        • Reijnen M.M.
        Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins.
        J Vasc Surg. 2013; 57: 445-450
        • Lane T.
        • Bootun R.
        • Dharmarajah B.
        • Lim C.S.
        • Najem M.
        • Renton S.
        • et al.
        A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins—final results of the Venefit versus Clarivein for varicose veins trial.
        Phlebology. 2017; 32: 89-98
        • Obi A.T.
        • Sutzko D.C.
        • Almeida J.I.
        • Kabnick L.
        • Cronenwett J.L.
        • Osborne N.H.
        • et al.
        First 10-month results of the Vascular Quality Initiative Varicose Vein Registry.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 312-320.e2
        • Witte M.E.
        • Holewijn S.
        • van Eekeren R.R.
        • de Vries J.P.
        • Zeebregts C.J.
        • Reijnen M.M.
        Midterm outcome of mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency.
        J Endovasc Ther. 2017; 24: 149-155
        • Monahan D.L.
        Can phlebectomy be deferred in the treatment of varicose veins?.
        J Vasc Surg. 2005; 42: 1145-1149
        • Hicks C.W.
        • DiBrito S.R.
        • Magruder J.T.
        • Weaver M.L.
        • Barenski C.
        • Heller J.A.
        Radiofrequency ablation with concomitant stab phlebectomy increases risk of endovenous heat-induced thrombosis.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 200-209
        • McAree B.
        • Ikponmwosa A.
        • Brockbank K.
        • Abbott C.
        • Homer-Vanniasinkam S.
        • Gough M.J.
        Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
        Eur J Vasc Endovasc Surg. 2012; 43: 721-725
        • Boersma D.
        • van Haelst S.T.
        • van Eekeren R.R.
        • Vink A.
        • Reijnen M.M.
        • de Vries J.P.
        • et al.
        Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the ClariVein OC device in an animal model.
        Eur J Vasc Endovasc Surg. 2017; 53: 290-298
        • Morrison N.
        • Gibson K.
        • Vasquez M.
        • Weiss R.
        • Cher D.
        • Madsen M.
        • et al.
        VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins.
        J Vasc Surg Venous Lymphat Disord. 2017; 5: 321-330
        • Gibson K.
        • Kabnick L.
        • Varithena 013 Investigator Group
        A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
        Phlebology. 2017; 32: 185-193
        • Leung C.C.
        • Carradice D.
        • Wallace T.
        • Chetter I.C.
        Endovenous laser ablation versus mechanochemical ablation with ClariVein in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trial.
        Trials. 2016; 17: 421
        • Argyriou C.
        • Papasideris C.
        • Antoniou G.A.
        • Georgakarakos E.
        • Papanas N.
        • Lazarides M.K.
        • et al.
        The effectiveness of various interventions versus standard stripping in patients with varicose veins in terms of quality of life.
        Phlebology. 2018; 33: 439-450